ADIPOQ and metabolic syndrome: Recent studies have demonstrated the relationship of the metabolic syndrome with PAH and highlighted the features of insulin resistance [7], adiponectin deficiency [8], dyslipidemia [9], fatty acid oxidation, and the tricarboxylic acid cycle [10] in the development of pulmonary vascular disease.